JMP Securities upgraded Regeneron (REGN) citing reduced competition for its Eylea drug following the setback for competitor Allergan's (AGN) DARPin in wet AMD.
Stocks rose on Thursday, with the S&P at a fresh intraday high, after strong job market data and on hopes the first …